BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2998 related articles for article (PubMed ID: 28390697)

  • 1. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Mortality Collaborators
    Lancet; 2017 Sep; 390(10100):1084-1150. PubMed ID: 28919115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diseases and Injuries Collaborators
    Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Diseases and Injuries Collaborators
    Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Risk Factors Collaborators
    Lancet; 2017 Sep; 390(10100):1345-1422. PubMed ID: 28919119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Mortality and Causes of Death Collaborators
    Lancet; 2016 Oct; 388(10053):1459-1544. PubMed ID: 27733281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Causes of Death Collaborators
    Lancet; 2017 Sep; 390(10100):1151-1210. PubMed ID: 28919116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Epilepsy Collaborators
    Lancet Neurol; 2019 Apr; 18(4):357-375. PubMed ID: 30773428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Child Mortality Collaborators
    Lancet; 2016 Oct; 388(10053):1725-1774. PubMed ID: 27733285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Risk Factors Collaborators
    Lancet; 2020 Oct; 396(10258):1223-1249. PubMed ID: 33069327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 150.